Mode
Text Size
Log in / Sign up
Phase 1 Completed N=7 Treatment

Exposure Therapy for Veterans With PTSD and Panic Attacks (Phase 1)

Source: ClinicalTrials.gov NCT01551199 ↗
Enrolled (actual)
7
Serious AEs
0.0%
Results posted
Jan 2015
Primary outcomePrimary: Clinician Administered PTSD Scale (CAPS) — 29.5 units on a scale

Summary

To evaluate the feasibility, acceptability and effectiveness of Multiple Channel Exposure Therapy-Veterans (MCET-V) as a treatment for returning service members with comorbid posttraumatic stress disorder (PTSD) and panic disorder (PD) in two phases. The first phase of the study will examine the feasibility and acceptability of MCET-V.

Outcome Measures

OutcomeResultp-value
PRIMARY
Clinician Administered PTSD Scale (CAPS)
17
SECONDARY
Anxiety Disorders Interview Schedule- DSM-IV (ADIS-IV)
100; 0

Eligibility Criteria

Inclusion Criteria

  • being a veteran of any era;
  • being enrolled in the Trauma Recovery Program (TRP) at the Michael E. DeBakey Veterans Affairs Medical Center (MEDVAMC), with a current diagnosis of PTSD and PD;
  • being stable on psychotropic medication for 4 weeks before study participation; and
  • being at least 18 years of age.

Exclusion Criteria

  • active substance dependence, or bipolar or psychotic disorders;
  • severe depression and active suicidal ideation and intent (based on Structured Clinical Interview for DSM-IV disorders [SCID-IV] & Beck Depression Inventory-2nd edition [BDI-II]);
  • cognitive impairment as indicated by the St. Louis University Mental Status exam (SLUMS); and
  • veterans currently receiving psychosocial treatment specifically targeting PTSD or panic symptoms.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01551199). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search